137 related articles for article (PubMed ID: 33533302)
1. Assessment of atherosclerotic cardiovascular disease risks between people living with HIV receiving first-line and second-line antiretroviral therapy in a resource-limited setting.
Tiarukkitsagul J; Sungkanuparph S
Int J STD AIDS; 2021 Apr; 32(5):421-426. PubMed ID: 33533302
[TBL] [Abstract][Full Text] [Related]
2. Changes in atherosclerotic cardiovascular disease risk over time among people living with HIV.
Chen W; Petoumenos K; Somia A; Edmiston N; Chaiwarith R; Woolley I; Ross J; Pujari S; Boettiger DC;
J Antimicrob Chemother; 2024 Apr; 79(4):897-902. PubMed ID: 38416697
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) risk prediction models.
Krikke M; Hoogeveen RC; Hoepelman AI; Visseren FL; Arends JE
HIV Med; 2016 Apr; 17(4):289-97. PubMed ID: 26268806
[TBL] [Abstract][Full Text] [Related]
4. Anemia in people on second line antiretroviral treatment in Lilongwe, Malawi: a cross-sectional study.
Ngongondo M; Rosenberg NE; Stanley CC; Lim R; Ongubo D; Broadhurst R; Speight C; Flick R; Tembo P; Hosseinpour MC
BMC Infect Dis; 2018 Jan; 18(1):39. PubMed ID: 29334932
[TBL] [Abstract][Full Text] [Related]
5. Atherosclerotic cardiovascular disease thresholds for statin initiation among people living with HIV in Thailand: A cost-effectiveness analysis.
Boettiger DC; Chattranukulchai P; Avihingsanon A; Chaiwarith R; Khusuwan S; Law MG; Ross J; Kiertiburanakul S
PLoS One; 2021; 16(9):e0256926. PubMed ID: 34499685
[TBL] [Abstract][Full Text] [Related]
6. Systemic Inflammation and the Increased Risk of Inflamm-Aging and Age-Associated Diseases in People Living With HIV on Long Term Suppressive Antiretroviral Therapy.
Babu H; Ambikan AT; Gabriel EE; Svensson Akusjärvi S; Palaniappan AN; Sundaraj V; Mupanni NR; Sperk M; Cheedarla N; Sridhar R; Tripathy SP; Nowak P; Hanna LE; Neogi U
Front Immunol; 2019; 10():1965. PubMed ID: 31507593
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of diabetes mellitus and hypertension in people living with human immunodeficiency virus on antiretroviral therapy in Gweru district, Zimbabwe.
Gonah L; Moodley I; Hlongwana K
Afr J Prim Health Care Fam Med; 2020 Aug; 12(1):e1-e6. PubMed ID: 32787407
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular disease risk in an urban African population: a cross-sectional analysis on the role of HIV and antiretroviral treatment.
Vos AG; Hoeve K; Barth RE; Peper J; Moorhouse M; Crowther NJ; Venter WDF; Grobbee DE; Bots ML; Klipstein-Grobusch K
Retrovirology; 2019 Dec; 16(1):37. PubMed ID: 31796103
[TBL] [Abstract][Full Text] [Related]
9. Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis.
Islam FM; Wu J; Jansson J; Wilson DP
HIV Med; 2012 Sep; 13(8):453-68. PubMed ID: 22413967
[TBL] [Abstract][Full Text] [Related]
10. Incidence of tuberculosis in HIV-infected adults on first- and second-line antiretroviral therapy in India.
Gupte AN; Kadam D; Sangle S; Rewari BB; Salvi S; Chavan A; Nimkar S; Golub J; Gupte N; Gupta A; Marbaniang I; Mave V
BMC Infect Dis; 2019 Oct; 19(1):914. PubMed ID: 31664933
[TBL] [Abstract][Full Text] [Related]
11. Relative risk of renal disease among people living with HIV: a systematic review and meta-analysis.
Islam FM; Wu J; Jansson J; Wilson DP
BMC Public Health; 2012 Mar; 12():234. PubMed ID: 22439731
[TBL] [Abstract][Full Text] [Related]
12. Comedication prescription patterns and potential for drug-drug interactions with antiretroviral therapy in people living with human immunodeficiency virus type 1 infection in Germany.
Lopes S; O'Day K; Meyer K; Van Stiphout J; Punekar Y; Radford M; Haas JS
Pharmacoepidemiol Drug Saf; 2020 Mar; 29(3):270-278. PubMed ID: 31950545
[TBL] [Abstract][Full Text] [Related]
13. Impact of Perceived Cardiovascular Risk on Cardiovascular Disease Prevention Behaviors in People With and Without HIV Infection.
Webel A; Horvat Davey C; Schexnayder J; Currie J; Al Battashi H; Chang J; Longenecker CT
J Acquir Immune Defic Syndr; 2020 Apr; 83(5):513-521. PubMed ID: 31914003
[TBL] [Abstract][Full Text] [Related]
14. Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa.
Onoya D; Hirasen K; van den Berg L; Miot J; Long LC; Fox MP
Drug Saf; 2018 Dec; 41(12):1343-1353. PubMed ID: 30043384
[TBL] [Abstract][Full Text] [Related]
15. Sex modifies the association between HIV and coronary artery disease among older adults in Uganda.
Longenecker CT; Bogorodskaya M; Margevicius S; Nazzinda R; Bittencourt MS; Erem G; Nalukwago S; Huaman MA; Ghoshhajra BB; Siedner MJ; Juchnowski SM; Zidar DA; McComsey GA; Kityo C
J Int AIDS Soc; 2022 Jan; 25(1):e25868. PubMed ID: 34995413
[TBL] [Abstract][Full Text] [Related]
16. Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial.
Baker JV; Sharma S; Achhra AC; Bernardino JI; Bogner JR; Duprez D; Emery S; Gazzard B; Gordin J; Grandits G; Phillips AN; Schwarze S; Soliman EZ; Spector SA; Tambussi G; Lundgren J;
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28533305
[TBL] [Abstract][Full Text] [Related]
17. Hypertension among persons living with HIV/AIDS and its association with HIV-related health factors.
Denu MKI; Revoori R; Buadu MAE; Oladele O; Berko KP
AIDS Res Ther; 2024 Jan; 21(1):5. PubMed ID: 38212762
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults.
Jantarapakde J; Phanuphak N; Chaturawit C; Pengnonyang S; Mathajittiphan P; Takamtha P; Dungjun N; Pinyakorn S; Pima W; Prasithsirikul W; Phanuphak P
AIDS Patient Care STDS; 2014 Jul; 28(7):331-40. PubMed ID: 24914459
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Subclinical Atherosclerosis and Risk of Atherosclerotic Cardiovascular Disease in Older Adults Living with HIV.
Aurpibul L; Srithanaviboonchai K; Rerkasem K; Tangmunkongvorakul A; Sitthi W; Musumari PM
AIDS Res Hum Retroviruses; 2019; 35(11-12):1136-1142. PubMed ID: 31382762
[TBL] [Abstract][Full Text] [Related]
20. Adherence to antiretroviral therapy and the associated factors among people living with HIV/AIDS in Northern Peru: a cross-sectional study.
Leyva-Moral JM; Loayza-Enriquez BK; Palmieri PA; Guevara-Vasquez GM; Elias-Bravo UE; Edwards JE; Feijoo-Cid M; Davila-Olano LY; Rodriguez-Llanos JR; Leon-Jimenez FE
AIDS Res Ther; 2019 Aug; 16(1):22. PubMed ID: 31462291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
